Distributor inventory | Cream
Fluocinolone acetonide 0.01% w/w + Hydroquinone 4% w/w + Tretinoin 0.05% w/w
Treatment of moderate to severe melasma (facial hyperpigmentation) and other hyperpigmentation disorders as prescribed
Hydroquinone reduces melanin formation by inhibiting tyrosinase, helping lighten dark patches. Tretinoin increases skin cell turnover and enhances penetration of hydroquinone. Fluocinolone acetonide is a mild corticosteroid that reduces inflammation and irritation from the other ingredients.
For external use only. Apply a thin layer once daily at night to affected areas on clean, dry skin, or as directed by a dermatologist. Avoid eyes, lips, corners of nose and broken/irritated skin; wash hands after use. Use sunscreen and protective clothing during daytime; avoid unnecessary sun exposure.
Common side effects of TRILUMA RD CREAM may include:
Use only under medical supervision; not for prolonged continuous use. Avoid use in pregnancy unless advised; do not use on large areas or under occlusion. Can cause skin thinning and steroid-related effects with overuse; may cause ochronosis (bluish-black pigmentation) with prolonged hydroquinone use. Avoid in children unless prescribed. Stop and consult doctor if severe irritation, swelling, blistering, or allergic reaction occurs. Avoid concomitant irritating products (scrubs, astringents) and waxing on treated areas; use broad-spectrum sunscreen.
